Chimerix steps toward safer stem-cell transplants with Phase 2 results Triangle Business Journal This particular study is unique in that patients were infected with the disease, an often fatal infection in pediatric and adult patients whose immune systems are compromised after a stem-cell transplant. The compound, CMX001, would be the first such ... |
